Yang, C., & Zhao, H. (2021). Tocilizumab in COVID-19 therapy: Who benefits, and how? Lancet.
Chicago Style citaatYang, Chengliang, en Hedi Zhao. "Tocilizumab in COVID-19 Therapy: Who Benefits, and How?" Lancet 2021.
MLA citatieYang, Chengliang, en Hedi Zhao. "Tocilizumab in COVID-19 Therapy: Who Benefits, and How?" Lancet 2021.
Let op: Deze citaties zijn niet altijd 100% accuraat.